The antibody drug conjugates market is witnessing significant advancements driven by novel biotherapeutics and targeted cancer therapies. This market’s evolution reflects increasing adoption of ADCs in oncology, alongside expanding research pipelines that are redefining treatment paradigms globally. https://www.feedsfloor.com/other/antibody-drug-conjugates-market-size-and-emerging-innovation-trends